Deutsch English Français

Contact

EP2454275

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...

Extract from the Register of European Patents

EP About this file: EP2454275

EP2454275 - PROCESS AND SYSTEM FOR OBTAINING BOTULINUM NEUROTOXIN [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 18.05.2018 Database last updated on 26.04.2025
Former	The patent has been granted Status updated on 09.06.2017
Former	Grant of patent is intended Status updated on 23.01.2017
Former	Examination is in progress Status updated on 08.11.2016
Most recent event Tooltip	10.07.2020	Lapse of the patent in a contracting state New state(s): AL	published on 12.08.2020 [2020/33]
Applicant(s)	For all designated states ALLERGAN, INC. 2525 Dupont Drive Irvine, CA 92612 / US
	[2017/28]
Former [2012/21]	For all designated states Allergan, Inc. 2525 Dupont Drive, T2-7H Irvine, CA 92612 / US
Inventor(s)	01 / TON, Jennifer L. 3595 Sego Street Irvine California 92606 / US
	02 / PATEL, Hemant A. 12 Twilight Lane Rancho Santa Margarita California 92688 / US
	03 / BATES, Ronald C. 457 Shadow Oaks Irvine California 92618 / US
	04 / AHMAD, Wajdie M. 2103 Anacapa Irvine California 92602 / US
	[2012/21]
Representative(s)	Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
	[2017/28]
Former [2012/21]	HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastraße 4 81925 München / DE
Application number, filing date	10733117.5	12.07.2010
	[2017/28]
	WO2010US41745
Priority number, date	US20090502181	13.07.2009 Original published format: US 502181
	[2012/21]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2011008713
	Date:	20.01.2011
	Language:	EN
	[2011/03]
	Type:	A1 Application with search report
	No.:	EP2454275
	Date:	23.05.2012
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 20.01.2011 takes the place of the publication of the European patent application.
	[2012/21]
	Type:	B1 Patent specification
	No.:	EP2454275
	Date:	12.07.2017
	Language:	EN
	[2017/28]
Search report(s)	International search report - published on:	EP	20.01.2011
Classification	IPC:	C07K14/33, C12N1/20, C12P21/02, A61K38/16	[2012/21]
	CPC:	C12N9/52 (EP,US); C07K14/33 (EP,CN,KR,US); A61K38/16 (KR); B01D15/361 (EP,US); B01D15/362 (EP,US); B01D15/363 (EP,US); (+) C07K1/00 (KR); C07K1/18 (KR,US); C12N1/20 (KR,US); C12P21/02 (CN,US); C12R2001/145 (US); C12Y304/24069 (EP,US); Y02A50/30 (EP) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/21]
Extension states	BA	Not yet paid
	ME	Not yet paid
	RS	Not yet paid
Title	German:	VERFAHREN UND SYSTEM ZUR HERSTELLUNG VON BOTULINUM NEUROTOXIN	[2016/34]
	English:	PROCESS AND SYSTEM FOR OBTAINING BOTULINUM NEUROTOXIN	[2012/21]
	French:	PROCÉDÉ ET SYSTÈME POUR OBTENIR LA NEUROTOXINE BOTULIQUE	[2016/34]
	Former [2012/21]	VERFAHREN UND SYSTEM ZUR GEWINNUNG VON BOTULINUMNEUROTXIN
	Former [2012/21]	PROCÉDÉ ET SYSTÈME D OBTENTION DE LA TOXINE BOTULINIQUE
Entry into regional phase	31.01.2012	National basic fee paid
	31.01.2012	Designation fee(s) paid
	31.01.2012	Examination fee paid
Examination procedure	31.01.2012	Examination requested [2012/21]
	28.08.2012	Amendment by applicant (claims and/or description)
	04.01.2013	Despatch of a communication from the examining division (Time limit: M04)
	14.05.2013	Reply to a communication from the examining division
	07.04.2014	Despatch of a communication from the examining division (Time limit: M04)
	01.08.2014	Reply to a communication from the examining division
	15.09.2015	Despatch of a communication from the examining division (Time limit: M04)
	13.01.2016	Reply to a communication from the examining division
	18.08.2016	Communication of intention to grant the patent
	21.10.2016	Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
	24.01.2017	Communication of intention to grant the patent
	26.05.2017	Fee for grant paid
	26.05.2017	Fee for publishing/printing paid
	26.05.2017	Receipt of the translation of the claim(s)
Divisional application(s)	EP17180720.9 / EP3252070
	EP19200775.5 / EP3640259
	EP22168797.3 Application refused : 23.09.2022
	EP22185200.7 / EP4141024
	EP23194794.6
	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 04.01.2013
Opposition(s)	13.04.2018	No opposition filed within time limit [2018/25]
Fees paid	Renewal fee
	25.07.2012	Renewal fee patent year 03
	29.07.2013	Renewal fee patent year 04
	28.07.2014	Renewal fee patent year 05
	27.07.2015	Renewal fee patent year 06
	27.07.2016	Renewal fee patent year 07
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	AL	12.07.2017
	HR	12.07.2017
	LT	12.07.2017
	LV	12.07.2017
	MK	12.07.2017
	MT	12.07.2017
	SM	12.07.2017
	[2020/33]
Former [2019/51]	HR	12.07.2017
	LT	12.07.2017
	LV	12.07.2017
	MK	12.07.2017
	MT	12.07.2017
	SM	12.07.2017
Former [2018/43]	HR	12.07.2017
	LT	12.07.2017
	LV	12.07.2017
	MT	12.07.2017
	SM	12.07.2017
Former [2018/27]	HR	12.07.2017
	LT	12.07.2017
	LV	12.07.2017
	SM	12.07.2017
Former [2018/15]	HR	12.07.2017
	LT	12.07.2017
	LV	12.07.2017
Former [2018/11]	HR	12.07.2017
	LT	12.07.2017
Former [2018/07]	LT	12.07.2017
Cited in	International search	[XI]WO2006096164 (ALLERGAN INC [US], et al);
		[XDI]US2006228780 (LUO MINGJIANG [US], et al);
	by applicant	US5512547
		US5696077
		US5756468
		US6087327
		US2003008367
		US6558926
		US2003118598
		US2006228780
		US7148041
		US7160699
		US7189541
		US7354740
		US7445914
		US7452697
		US20060452570
		US20060609449
		US20070932689
		US20070932789
		US20080098899
		US20080234537

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.32; 35p